As of 2025-07-02, the Intrinsic Value of Medpace Holdings Inc (MEDP) is 351.85 USD. This MEDP valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 321.06 USD, the upside of Medpace Holdings Inc is 9.60%.
The range of the Intrinsic Value is 257.96 - 588.75 USD
Based on its market price of 321.06 USD and our intrinsic valuation, Medpace Holdings Inc (MEDP) is undervalued by 9.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 257.96 - 588.75 | 351.85 | 9.6% |
| DCF (Growth 10y) | 314.05 - 687.19 | 420.68 | 31.0% |
| DCF (EBITDA 5y) | 260.55 - 332.08 | 276.67 | -13.8% |
| DCF (EBITDA 10y) | 313.87 - 413.02 | 342.02 | 6.5% |
| Fair Value | 362.20 - 362.20 | 362.20 | 12.81% |
| P/E | 288.00 - 517.52 | 408.62 | 27.3% |
| EV/EBITDA | 209.89 - 314.24 | 248.95 | -22.5% |
| EPV | 162.96 - 213.70 | 188.33 | -41.3% |
| DDM - Stable | 100.61 - 305.70 | 203.15 | -36.7% |
| DDM - Multi | 125.04 - 308.89 | 179.59 | -44.1% |
| Market Cap (mil) | 9,227.41 |
| Beta | 0.97 |
| Outstanding shares (mil) | 28.74 |
| Enterprise Value (mil) | 8,785.97 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.17% |
| Cost of Debt | 4.48% |
| WACC | 6.51% |